Form S-3ASR Mersana Therapeutics,
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Mersana (MRSN) PT Raised to $15 at Citi, Opens Catalyst Watch
May 10, 2023 3:24 PM EDTCiti analyst Ashiq Mubarack raised the price target on Mersana (NASDAQ: MRSN) to $15.00 (from $12.00) while maintaining a Buy rating.
The analys topens a 90-day upside catalyst watch commenting "In mid-2023, MRSN will share topline results from the pivotal UPLIFT Ph2 trial evaluating UpRi in... More
Mersana Therapeutics (MRSN) Files Mixed Shelf
May 9, 2023 4:15 PM EDTMersana Therapeutics (NASDAQ: MRSN) has filed mixed shelf of:
Common Stock
Preferred Stock
Warrants
Units
